Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between γ2-MSH and ACTH-(1-24)

British Journal of Pharmacology

Volumn 120, Issue 8, 1997, Pages 1561-1567

  Van Bergen, Patricia ^a   Kleijne, Jeroen A ^a   De Wildt, Dick J ^a,b   Versteeg, Dirk H G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

ACTH (1 24) (adrenocorticotropin (1 24)); Blood pressure; Functional antagonism; Heart rate; Melanocortin receptor subtypes; Nle4,D Phe7 MSH; 2 MSH ( 2 melanocyte stimulating hormone)

Indexed keywords

CATECHOLAMINE; INTERMEDIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; RECEPTOR SUBTYPE; TETRACOSACTIDE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; TACHYCARDIA;

EID: 0030895471     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701065     Document Type: Article

References (32)

1. BRODY, M.J., FABER, J.E., MANGIAPANE, M.L. & PORTER, J.P. (1984). The central nervous system and the prevention of hypertension. In Handbook of Hypertension, Vol. 4: Experimental and Genetic Models of Hypertension, ed. De Jong, W., pp. 474-494, Amsterdam: Elsevier Science Publishers.
2. BUCKINGHAM, J.C. & HODGES, J.R. (1975). Interrelationships of pituitary and plasma corticosterone during adrenocortical regeneration in rat. J. Endocrinol., 67, 411-417.
3. 2-MSH. Clin. Exp. Hypertension, A6, 1727-1730.
4. CHHAJLANI, V., MUCENIECE, R. & WIKBERG, J.E.S. (1993). Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun., 195, 866-873.
5. CHHAJLANI, V. & WIKBERG, J.E.S (1992). Molecular cloning of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett., 309, 417-420.
6. DE WIED, D. & JOLLES, J. (1982). Neuropeptides derived from proopiomelanocortin: behavioral, physiological, and neurochemical effects. Physiol. Rev., 62, 976-1059.
7. 2-melanocyte-stimulating hormone on cerebral blood flow in rats. J. Cardiovasc. Pharmacol., 25, 898-905.
8. 2-melanocyte-stimulating hormone and related melanotropins depend on the arousal potential of the rat. Eur. J. Pharmacol., 233, 157-164.
9. EBERLE, A.N. (1988). The Melanotropins. Chemistry, Physiology and Mechanisms of Action. New York: S Karger Publishers.
10. GANTZ, I., KONDA, Y., TASHIRO, T., SHIMOTO, Y., MIWA, H., MUNZERT, G., WATSON, S.J., DELVALLE, J & YAMADA, T. (1993). Molecular cloning of a novel melanocortin receptor. J. Biol. Chem., 268, 8246-8250.
11. GÖTHERT, M. (1984). Facilitatory effect of adrenocorticotropic hormone and related peptides on Ca2+ -dependent noradrenaline release from sympathetic nerves. Neuroscience, 11, 1001-1009.
12. GRIFFON, N., MIGNON, V., FACCHINETTl, P., DIAZ, J., SCHWARTZ, J.-P. & SOKOLOFF, P. (1994). Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem. Biophys. Res. Commun., 200, 1007-1014.
13. GRUBER, K.A. & CALLAHAN, M.F. (1989). ACTH-(4-10) through γ-MSH: evidence for a new class of central autonomic nervous system-regulating peptides. Am. J. Physiol., 257, R681-R694.
14. HOLZWARTH, M.A., SHINSAKO, J. & DALLMAN, M.F. (1980). Adrenal regeneration. Time course, effect of hypothalamic hemi-island and response to unilateral adrenalectomy. Neuroendocrinology, 31, 168-176.
15. JAQUES, R. (1965). Non-specific effects of synthetic corticotrophin polypeptides. Int. Arch. Allergy, 28, 221-230.
16. KLEIN, M.C., HUTCHINS, P.M., LYMANGROVER, J.R. & GRUBER, K.A. (1985). Pressor and cardioaccelerator effects of gamma MSH and related peptides. Life Sci., 36, 769-775.
17. LOW, M.J., SIMERLY, R.B. & CONE, R.D (1994). Receptors for the melanocortin peptides in the central nervous system. Curr. Opin. Endocrinol. Diabetes, 79-88.
18. LUDBROOK, J. & VENTURA, S. (1995). ACTH-(1-24) blocks the decompensatory phase of the haemodynamic response to acute hypovolaemia in conscious rats. Eur. J. Pharmacol., 275, 267-275.
19. 3H-norepinephrine by the rat atria. Pharmacol. Biochem. Behav., 30, 391-396.
20. MOUNTJOY, K.G., MORTRUD, M.T., LOW, M.J., SIMERLY, R.B. & CONE, R.D. (1994). Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol., 8, 1298-1308.
21. MOUNTJOY, K.G., ROBBINS, L.S., MORTRUD, M.T. & CONE, R.D. (1992). The cloning of a family of genes that encode the melanocortin receptors. Science, 257, 1248-1251.
22. NAKAMURA, M., MATSUDA, S., UEDA, M. & TANAKA, A. (1976). Depressor effect of synthetic peptides related to ACTH on blood pressure in rats. Experientia, 32, 368-369.
23. ROSELLI-REHFUSS, L., MOUNTJOY, K.G., ROBBINS, L.S., MORTRUD, M.T., LOW, M.J., TATRO, J.B., ENTWISTLE, M.L. SIMERLY, R.B. & CONE, R.D. (1993). Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A., 90, 8856-8860.
24. SAWYER, T.K., SANFILIPPO, P.J., HRUBY, V.J., ENGEL, M.H., HEWARD, C.B., BURNETT, J.B. & HADLEY, ME. (1980). 4-Norleucine, 7-D-phenylalanine-α-melanocyte-stimulating hormone. A highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. U.S.A., 77, 5754-5758.
25. SZABO, B., HEDLER, L., LICHTWALD, K. & STARKE, K. (1987). ACTH increases noradrenaline release in pithed rabbits with electrically stimulated sympathetic outflow. Eur. J. Pharmacol., 136, 391-399.
26. SZABO, B., HEDLER. L. & STARKE, K. (1989). Facilitation of the release of noradrenaline: an extra-adrenal effect of adrenocorticotropic hormone. Resuscitation, 18, 229-242.
27. 2-MSH in spontaneously hypertensive and normotensive rats. Am. J. Physiol., 262, R77-R84.
28. UEDA, M., MATSUDA, S., KAWAKAMI, M. & TAKEDA, H. (1970). Depressor mechanism of synthetic ACTH (50022). Jap. J. Pharmacol., 20, 585-598.
29. VAN BERGEN, P., JANSSEN, P.M.L., HOOGERHOUT, P., DE WILDT, D,J. & VERSTEEG, D.H.G. (1995). Cardiovascular effects of γ-MSH/ACTH-like peptides: structure-activity relationship. Eur. J. Pharmacol., 294, 795-803.
30. VAN BERGEN, P., VAN DER VAART, J.G.M., KASBERGEN, C.M., VERSTEEG, D.H.G. & DE WILDT, D.J. (1996). Structure-activity analysis for the effects of γ-MSH/ACTH-like peptides on cerebral hemodynamics in rats. Eur. J. Pharmacol., 318, 357-368.
31. 2-MSH on blood pressure following intracerebrovascular and intracisternal administration. J. Cardiovasc. Pharmacol., 21, 907-911.
32. WEINDL, A. (1973). Neuroendocrine aspects of circumventricular organs. In Frontiers in Neuroendocrinology, ed. Ganong, W.F. & Scapagnini, U., pp. 3-32. Oxford: Oxford University Press.